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Abstract It was reported that human hematopoietic stem cells
in bone marrow were restricted to the CD34+KDR+ cell
fraction. We found that expression levels of Flk-1, a mouse
homologue of KDR, were low or undetectable in mouse Lin3c-
Kit+Sca-1+CD34low=3 cells as well as Hoechst333423 cells (side
population), which have long-term reconstitution capacity.
Furthermore, neither Flk-1+CD34low=3 cells nor Flk-1+CD34+
cells had long-term reconstitution capacity in mouse. Taken
together with other observations using Flk-1-deficient mice, these
results indicate that Flk-1 is essential for the development of
hematopoietic stem cells in embryo but not for the function of
hematopoietic stem cells in adult mouse bone marrow. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Studies on hematopoietic stem cells have been hindered by
lack of a de¢nitive positive marker. The membrane phospho-
glycoprotein CD34 has been used as a useful marker of hu-
man hematopoietic stem/progenitor cells, and various types of
colony-forming activity in bone marrow, cord blood, and mo-
bilized peripheral blood have been proven to be included in
the CD34 population in human [1,2]. Clinical transplanta-
tion studies using enriched CD34 bone marrow cells have
also demonstrated the presence of hematopoietic stem cells
with long-term reconstitution ability within this fraction
[3,4]. Based on these ¢ndings, the current experimental and
clinical strategies for the enrichment of human hematopoietic
stem cells rely on the positive selection of the CD34 antigen.
However, studies on the mouse system showed that hemato-
poietic stem cells with long-term reconstitution capacity were
present in the CD34low=3 cell population rather than in
CD34 cells [5,6]. Actually, a single mouse Lin3c-KitSca-
1CD34low=3 cell transplanted into lethally irradiated mice
was able to sustain long-term multilineage engraftment [5].
Ito et al. [7], however, recently reported that developmental
changes of CD34 expression from the positive to negative
state took place between 7 and 10 weeks of age in mouse
long-term engrafting cells, and that about 20% of adult hem-
atopoietic stem cells remained CD34.
Recently, Ziegler et al. [8] reported that vascular endothelial
growth factor receptor KDR/VEGFR2, Flk-1 in mice, is a
major functional marker for postnatal hematopoietic stem
cells in human. They described that human pluripotent hem-
atopoietic stem cells in bone marrow were restricted to the
CD34KDR cell fraction, and that lineage-committed hem-
atopoietic progenitor cells were in the CD34KDR3 subset.
The KDR was predominantly expressed in endothelial cells
[9], and the mRNA was detected in human hematopoietic
stem cells and megakaryocytes [10]. On the other hand, it
has been suggested that Flk-1 plays an important role in em-
bryonic hematoangiogenesis in mouse [11,14]. Flk-1 was ex-
pressed in the blood islands in the yolk sac of embryos [12] as
well as in endothelial cells of the vascular sprouts and branch-
ing vessels of embryonic and early postnatal brain [11]. Tar-
geted gene disruption studies demonstrated that Flk-1 was
required for initiation of hematolymphopoiesis and vasculo-
genesis [13], implying that Flk-1 is required for generation of
hemangioblasts, the stem cells for both hematolymphopoietic
and endothelial lineage [14]. It is not known, however,
whether Flk-1 is also expressed in hematopoietic stem
cells in adult mouse bone marrow as shown in the human
system.
Hematopoietic stem cells can also be identi¢ed based on
their ability to e¥ux £uorescent dyes, such as Hoechst33342
and Rhodamine123. Goodell et al. [15] used Hoechst33342
staining of bone marrow cells to identify a minor fraction
of side population (SP) cells highly enriched for repopulating
activity. This SP phenotype identi¢es a primitive subset of
stem cells in multiple mammalian species. Nowadays, both
Rhodamine123 and Hoechst33342 are often used to identify
the more limited hematopoietic stem cell population in SP
cells [16].
Here we examined whether mouse hematopoietic stem cells
in bone marrow, Lin3c-KitSca-1CD34low=3 cells and SP
cells, express Flk-1, and whether Flk-1 cells have long-term
reconstitution ability. We found that mouse hematopoietic
stem cells are Flk-13 or Flk-1low and that Flk-1 cells had
no long-term reconstitution capacity in mouse. We therefore
concluded that Flk-1 is not essential for mouse hematopoietic
stem cells. We discuss here the role of Flk-1 in hematopoietic
stem cells.
2. Materials and methods
2.1. Mice
C57BL/6 mice (Ly-5.2) were purchased from Nihon SLC (Hama-
matsu, Japan) and their congenic strain C57BL/6-Ly-5.1 Pep3b (Ly-
5.1) was obtained from Sankyo Laboratory Service (Tsukuba, Japan).
8 to 10-week-old female mice were used as recipients in transplanta-
tion experiments.
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2.2. Antibodies
Monoclonal antibodies against the following surface molecules were
used: £uorescein isothiocyanate (FITC)-labeled anti-CD34 (RAM34),
biotin-labeled anti-CD34 (RAM34), phycoerythrin (PE)-labeled anti-
Flk-1 (Avas 12K1), anti-Sca-1 (E13-161.7), PE-labeled anti-Sca-1, al-
lophycocyanin (APC)-labeled anti-c-Kit (2B8), FITC-labeled anti-Ly-
5.1 (A20) antibodies (BD Pharmingen, San Diego, CA, USA). For
isotype control, FITC-labeled rat IgG2a/U and PE-labeled rat IgG2a/U
(BD Pharmingen #553929 and #553930) were used. Texas Red-con-
jugated donkey anti-rat IgG (Jackson ImmunoResearch Laboratories,
West Grove, PA, USA) was used to visualize unlabeled anti-Sca-1
antibody.
2.3. Preparation of bone marrow cells and depletion of
lineage-positive cells
Bone marrow cells were prepared by £ushing the femurs and tibias
with phosphate-bu¡ered saline (PBS) containing 2% inactivated fetal
calf serum (FCS). The cell suspension was overlaid on Lymphoprep
(Nycomed, Oslo, Norway) and centrifuged at 550Ug for 15 min. The
low-density cells were harvested and washed with PBS. In some cases,
bone marrow cells were depleted of lineage-positive cells using a mag-
netic particle concentrator (Dynal MPC-1; Dynal, Oslo, Norway).
Cells were reacted with biotinylated anti-lineage antibodies (Mac-1,
Gr-1, B220, CD4, CD8 and Ter119) (BD Pharmingen) for 30 min,
absorbed to streptavidin magnetic beads (Dynabeads M-280; Dynal)
for 30 min and separated on MPC-1 equipment for 2 min. The non-
adherent (lineage-negative) cells were collected and stained with the
subsequent antibodies as indicated.
2.4. Staining of Sca-1, c-Kit, CD34 and Flk-1
For ¢ve-color analysis, the nucleated cells (5U108 cells/ml) were
suspended in staining medium (PBS containing 2% FCS and 0.05%
NaN3), and incubated with anti-Sca-1 antibody on ice for 30 min.
After washing, the cells were incubated with Texas Red-conjugated
donkey anti-rat IgG antibody on ice for 30 min. After washing, the
lineage-positive cells were depleted as described above, followed by
staining with PE-labeled anti-Flk-1, FITC-labeled anti-CD34 and
APC-labeled anti-c-Kit antibodies on ice for 30 min and washed.
Immediately prior to £uorescence-activated cell scanning (FACS)
analysis, 1 Wg/ml propidium iodide (PI) (Sigma, St. Louis, MO,
USA) was added to the cell suspensions.
2.5. Preparation of SP cells
Bone marrow cells were suspended in PBS containing 2% FCS at
the concentration of 106 cells/ml, incubated with 5 Wg/ml
Hoechst33342 (Sigma) at 37‡C for 90 min and washed. When prepar-
ing Rhodamine1233 SP cells, the Hoechst33342-stained cells were
further incubated with 0.1 Wg/ml Rhodamine123 (Sigma) at 37‡C
for 60 min. For staining of the cells with cell surface antigens, the
cells suspended at 5U108 cells/ml in staining media were incubated
with the appropriate antibodies on ice for 30 min. The cells were kept
on ice until being analyzed. Immediately prior to FACS analysis or
sorting, 1 Wg/ml PI was added to the cell suspensions.
2.6. Flow cytometry
Cells were analyzed and sorted on a FACSVantageSE1 (Beckton
Dickinson Bioscience, San Jose, CA, USA). Hoechst33342 was excited
at 351 nm and its £uorescence emission was detected at two wave-
lengths using 424/44 (blue) and 675/20 (red) bandpass ¢lters (Omega
Optical, Brattleboro, VT, USA) [15]. A 560 nm short pass dichroic
mirror (Omega Optical) was used to separate these emission wave-
lengths. Fluorescence from the Hoechst dye was acquired in linear
scales. Rhodamine123 was excited at 488 nm and its £uorescence
emission was detected with 530/30 bandpass ¢lter (Omega Optical).
Fluorescence from the Rhodamine dye was acquired in log scales.
Fluorescence emission of FITC, PE, APC, Texas Red and PI was
detected using standard ¢lters.
2.7. Long-term reconstitution assays
The Ly-5.2 recipients were irradiated with 850 rad given in a single
dose from an X-ray source operated at 150 kV delivering 90 rad/min.
Progenitor cells sorted from Ly-5.1 donors were injected into the
irradiated recipients along with 2U105 whole bone marrow cells
from normal Ly-5.2 mice. All animal care was in accordance with
institutional guidelines. For the analysis of reconstitution, mice were
bled from the tail and assayed for the presence of Ly-5.1-positive cells.
Blood of recipient mice was collected in PBS with 10 mM EDTA.
Erythrocytes were eliminated by lysis with 155 mM NH4Cl. The re-
maining cells were ¢ltered through nylon mesh, stained with anti-Ly-
5.1 antibody and analyzed by FACS.
3. Results and discussion
Ziegler et al. [8] recently described that human hemato-
poietic stem cells were restricted to the CD34KDR cell
fraction in bone marrow, and that lineage-committed hema-
topoietic progenitor cells were in the CD34KDR3 subset.
Therefore, we examined the expression level of Flk-1, a mouse
homologue of KDR/VEGFR2, in mouse hematopoietic stem
cells. First of all, the expression of Flk-1 was examined in
Lin3c-KitSca-1CD34low=3 cells. The Lin3 bone marrow
cells were gated on c-KitSca-1 cells (Fig. 1A), and Fig.
1B shows the dotplot of Flk-1 versus CD34 on these cells.
The results indicated that Lin3c-KitSca-1CD34low=3 cells
were Flk-13 or Flk-llow. These results suggest that Flk-1 is
not a useful marker for isolation of mouse hematopoietic
stem cells in bone marrow, and that Flk-1 is not essential
for hematopoietic stem cells in mouse bone marrow.
Fig. 1. Mouse Lin3c-KitSca-1CD34low=3 cells are Flk-13 or Flk-1low. A: Expression of Sca-1 and c-Kit on mouse Lin3 bone marrow cells.
The c-KitSca-1 cells were grated. Lin3 bone marrow cells (2U105) were analyzed. B: Expression of Flk-1 and CD34 on c-KitSca-1 cells.
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Similarly, the expression of Flk-1 and CD34 on mouse SP
cells was examined. The bone marrow cells were gated on the
SP region (Fig. 2A), and Fig. 2B shows the dotplot of Flk-1
versus CD34 of the SP cells. It was found that most of the SP
cells (about 96%) were Flk-llow=3CD34low=3 and some (about
3%) were Flk-1low=3CD34, and that SP cells did not contain
Flk-1 cells at all. These results con¢rm that Flk-1 is not
essential for mouse hematopoietic stem cells.
To test whether the Flk-1 population in mouse bone mar-
row cells has engraftment activity, Flk-1CD34 cells, Flk-
1CD34low=3 cells and Rhodaminelow=3 SP cells were pre-
pared from Ly-5.1 mice. Fig. 3 shows the expression pro¢le
of Flk-1 and CD34 on mouse bone marrow cells. Only 0.27%
of mouse bone marrow cells were Flk-1 cells, and Flk-
1CD34 cells were constituted with only 0.09% of mouse
bone marrow cells. The Flk-1CD34low=3 cells were 0.18%
of mouse bone marrow cells. The isotype control antibodies
(FITC- and PE-labeled rat IgG2a/U) did not stain these cells
(data not shown). One hundred cells of each fraction were
transplanted into lethally irradiated Ly-5.2 recipients. The pu-
rity of the transplanted cells was about 99% (data not shown).
The level of engraftment was determined by measuring the
percentage of donor peripheral blood nucleated cells 3 and
6 months after transplantation. While Rhodaminelow=3 SP
cells, the more restricted population of SP cells, were success-
fully transplanted into the recipients over 6 months (18 out of
20 recipients) (Fig. 4A), neither Flk-1CD34 cells (Fig. 4B)
nor Flk-lCD34low=3 cells (Fig. 4C) were able to reconstitute
lymphohematopoiesis at all (none of 20 recipients) at 3 months
or 6 months after transplant. These results suggest that Flk-1
cells in mouse bone marrow have no long-term reconstitution
ability and are not hematopoietic stem cells, and con¢rm that
Flk-1 is not functionally essential for mouse hematopoietic
stem cells.
While it has been demonstrated that human hematopoietic
stem cells were restricted to the CD34KDR cell fraction [8],
mouse hematopoietic stem cells were found not to express
KDR homologue Flk-1. This ¢nding is analogous to the
case of CD34, which has been proved to be a crucial marker
for isolation of human and mouse hematopoietic stem cells.
These di¡erences may be due to the fact that CD34 and
KDR/Flk-1 are not common cell surface molecules that are
biologically critical to be hematopoietic stem cells in any spe-
cies. Therefore, identi¢cation of cell surface markers, which
are de¢nitively required for self-renewal of hematopoietic
stem cells and/or for multipotency of hematopoietic stem cells,
is awaited for the simple and easy isolation of hematopoietic
stem cells in any species and for clinical applications.
Shalaby et al. [13] examined the developmental potential of
Flk-1-de¢cient ES cells in chimeras, and found that these cells
contribute neither to primitive nor de¢nitive hematopoiesis.
Further, cells lacking Flk-1 were unable to reach the correct
location to form blood islands. They suggested that Flk-1 is
involved in the movement of cells from the posterior primitive
streak to the yolk sac and to the intraembryonic sites of early
hematopoiesis. Hidaka et al. [17] also examined Flk-1-de¢-
cient ES cells for their hematopoietic potential in vitro during
embryoid body formation or when cultured on the stromal
cell line OP9. They found that Flk-1 plays a role in regulating
Fig. 2. Mouse SP cells are Flk-1low=3. A: Mouse bone marrow cells stained with Hoechst33342 (4U106 cells). The SP cells were gated.
B: Staining pro¢le of Flk-1 versus CD34 on SP cells.
Fig. 3. Expression of Flk-1 and CD34 in mouse bone marrow cells.
Bone marrow cells (2U105) were analyzed. The Flk-1CD34 cells
and Flk-1CD34low=3 cells used for transplant experiments are
gated.
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the migration of early mesodermally derived precursors into a
microenvironment, which is permissive for hematopoiesis.
Kabrun et al. [12] investigated the expression pattern of the
Flk-1 during mouse embryonic hematopoiesis, and found that
embryos at day 8.5 of gestation contained Flk-1 hemato-
poietic precursors, whereas day 12.5 fetal liver contained
few Flk-1 cells that showed little hematopoietic potential.
Furthermore, they showed that all day 4 embryoid bodies-
derived hematopoietic precursors, which were generated
from ES cells di¡erentiated in culture, were Flk-1, whereas
greater than 95% of those found within the day 12 embryoid
bodies were Flk-13. These results indicated that Flk-1 is ex-
pressed in early hematopoietic precursors that represent the
onset of embryonic hematopoiesis. These ¢ndings show that
Flk-1 may be essential for embryonic hematopoiesis but not
for hematopoiesis in adult mouse bone marrow. Therefore,
hematopoietic stem cells derived from adult mouse bone mar-
row do not necessarily have to express Flk-1 for their hema-
topoietic function, although KDR expression remains in hu-
man adult hematopoietic stem cells.
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Fig. 4. No long-term reconstitution activity in Flk-1 bone marrow cells. The Rhodamine123low=3 SP cells (A), Flk-1CD34 cells (B) or Flk-
1CD34low=3 cells (C) prepared from Ly-5.1 mice were transplanted into lethally irradiated Ly-5.2 recipients, and the representative data are
shown. The level of engraftment was determined by measuring the donor-derived peripheral blood nucleated cells 6 months after transplanta-
tion.
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